Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
ohm20's Profile
Displaying 5951-6000 of 6050 result(s).
CYDY CytoDyn Inc
06/21/2019 1:20:22 PM
new video (2)
CYDY CytoDyn Inc
06/19/2019 9:31:53 PM
It's net tangible assets of $2 mill
CYDY CytoDyn Inc
06/19/2019 5:44:17 PM
Here are the guidelines - $2/share
CYDY CytoDyn Inc
06/19/2019 6:54:10 AM
"I am about 60% down in my account
CYDY CytoDyn Inc
06/19/2019 3:47:36 AM
When $5? After it crosses $2 and ge
CYDY CytoDyn Inc
06/17/2019 6:10:14 AM
Must be this study with 43 patients
CYDY CytoDyn Inc
06/08/2019 4:03:42 PM
FDA Grants Palbociclib Accelerated
CYDY CytoDyn Inc
06/08/2019 3:58:02 PM
Interesting read on early approval
CYDY CytoDyn Inc
06/08/2019 3:42:04 PM
A handful of cancer drugs have been
CYDY CytoDyn Inc
06/08/2019 3:29:30 PM
If you look at the previous compani
CYDY CytoDyn Inc
06/07/2019 9:08:22 AM
May be of interest to those promoti
CYDY CytoDyn Inc
06/07/2019 7:54:20 AM
With the high death rate in TNBC an (1)
CYDY CytoDyn Inc
06/07/2019 7:22:33 AM
Rarely will insurance companies pay
CYDY CytoDyn Inc
06/07/2019 1:15:19 AM
New Indications? While reading a pa
CYDY CytoDyn Inc
06/06/2019 6:50:09 PM
No parameters to gauge it by. If in (1)
CYDY CytoDyn Inc
06/06/2019 6:03:42 PM
From what I read doing my original
CYDY CytoDyn Inc
06/06/2019 5:35:49 PM
I just listened to the conference p (2)
CYDY CytoDyn Inc
06/05/2019 8:05:58 PM
The share price deserves to go down
CYDY CytoDyn Inc
06/03/2019 5:10:43 PM
Lerolimab selectively blocks CCR5 w (1)
CYDY CytoDyn Inc
06/01/2019 2:35:54 PM
From a very early paper " (CCR5 del
CYDY CytoDyn Inc
06/01/2019 2:02:01 PM
"This paper and the following two b
CYDY CytoDyn Inc
05/30/2019 1:18:43 PM
RP and NP are both going to make su
CYDY CytoDyn Inc
05/30/2019 1:12:34 PM
That's exactly where I think leronl
CYDY CytoDyn Inc
05/30/2019 11:36:03 AM
Pembrolizumab is the newest approve
CYDY CytoDyn Inc
05/30/2019 7:11:58 AM
CytoDyn and Samsung BioLogics Forma
CYDY CytoDyn Inc
05/30/2019 6:59:36 AM
CytoDyn to Present at the 9th Annua
CYDY CytoDyn Inc
05/29/2019 9:55:02 PM
Investor Presentation
CYDY CytoDyn Inc
05/29/2019 6:11:01 PM
finesand had to cover her shorts or
CYDY CytoDyn Inc
05/25/2019 6:08:32 PM
With total potential shares of 700m
CYDY CytoDyn Inc
05/23/2019 5:59:01 PM
The success rate of trials from pre
CYDY CytoDyn Inc
05/23/2019 4:34:30 PM
"Theranos" I see great minds think
CYDY CytoDyn Inc
05/23/2019 4:31:51 PM
For real or the next Theranos? If t
CYDY CytoDyn Inc
05/22/2019 12:34:19 PM
I wonder if Lawman will be there to (1)
CYDY CytoDyn Inc
05/22/2019 12:27:36 PM
I would think if there was a reduct
CYDY CytoDyn Inc
05/21/2019 10:11:01 AM
https://www.otcmarkets.com/stock/C
CYDY CytoDyn Inc
05/19/2019 12:07:51 AM
BIT225's disruption of vpu inhibiti
CYDY CytoDyn Inc
05/18/2019 8:56:56 AM
Given the results from leronlimab i
CYDY CytoDyn Inc
05/18/2019 8:44:41 AM
HIV exclusively infects CD4+ cells
CYDY CytoDyn Inc
05/18/2019 7:40:41 AM
You are correct delta32. is the mut
CYDY CytoDyn Inc
05/17/2019 8:12:54 PM
Since myeloablative pre-treatment t
CYDY CytoDyn Inc
05/17/2019 5:47:59 PM
CD4+ memory T-cells (where hidden H
CYDY CytoDyn Inc
05/17/2019 10:15:06 AM
Leronlimab just blocks the CCR5 rec
CYDY CytoDyn Inc
05/16/2019 7:56:31 PM
I have no medical background but re
CYDY CytoDyn Inc
05/16/2019 7:00:46 PM
What I just posted over at the SESN
CYDY CytoDyn Inc
05/16/2019 6:45:24 PM
We'll have CCR5 expression covered,
CYDY CytoDyn Inc
05/16/2019 10:24:11 AM
They won't, but if they pulled the
CYDY CytoDyn Inc
05/16/2019 9:50:54 AM
Maybe we need Jim Cramer to short i
CYDY CytoDyn Inc
05/15/2019 7:55:08 PM
Possibly the Westgate New York Gran
CYDY CytoDyn Inc
05/15/2019 7:41:42 PM
"The possibility of combing leronli
CYDY CytoDyn Inc
05/15/2019 7:32:59 PM
They need to release those videos i
Go to page:
  • << First
  • < Previous
  • 119
  • 120
  • Next >

Recent Articles

  • Shifting Trends in the Housing Market: Insights for Investors
  • Legal Action for Unicoin Investors: Understand Your Rights
  • PRA Group Initiates €300 Million Senior Notes Offering
  • Arco Vara AS Bonds Subscription: Breaking New Grounds
  • Havila Kystruten AS Reveals Positive Q3 EBITDA Projections
  • Fluence Partners with DRI for Major Battery Storage Project in Poland
  • Leadership Changes: Wolters Kluwer's New Board Nominations
  • Explore the Rich Culture of Japanese Matcha With Special Promotion
  • TransMedics Partners with Mercedes-Benz for Organ Transport Innovation
  • Raytron's Innovative OGI Cameras Enhance Ozone Layer Protection
  • TransMedics and Mercedes-Benz Forge Game-Changing Alliance
  • WUSD Cross-Chain Bridging Launches on Stargate Finance Today
  • Ericsson Announces Major Partnership with VodafoneThree in the UK
  • Sampo plc's Recent Share Buyback Program Insights
  • CROSSJECT Receives Boost from BARDA for ZEPIZURE Development
  • Market Analysis: Dow Futures Decline as Gold Surges Towards $3,700
  • Dogecoin's Market Struggles Amid ETF Launch Challenges
  • Understanding Tolebrutinib's Regulatory Journey in MS Treatment
  • Exploring Corbion's Recent Share Buyback Developments
  • Ipsen Launches Phase III for Groundbreaking IPN10200 in Aesthetics
  • Idorsia Expands Global Presence with QUVIVIQ Launch in China
  • Efficacy of Roche's Giredestrant in Advanced Breast Cancer
  • Prosafe SE Reports Strong Fleet Performance and Outlook
  • IPC Announces Strategic Move to Strengthen Bond Presence
  • IPC Plans to Hold Fixed Income Investor Meetings to Refinance Bonds
  • Sanofi's Tolebrutinib Update: FDA Review Extended for MS Treatment
  • International Petroleum Corporation Plans New Bond Issuance
  • Razor Labs and Process Automation Join Forces for AI Advancement
  • Apple's iPhone 17 Demand Booms as Price Target Reaches New Heights
  • Elon Musk and Trump Meet: Implications for Tesla and SpaceX
  • Revolutionizing Travel Payments with One Source Orchestration
  • Razor Labs and Process Automation Team Up for AI in Mining
  • Innovative Consortium Targets Climate-Resilient Food Production
  • IP Excellera's New Office Makes Strategic Mark in Abu Dhabi
  • Sanofi and Regeneron: Advancements in CSU Treatment with Dupixent
  • Sanofi and Regeneron’s Dupixent Receives Positive CHMP Opinion
  • VT Markets Celebrates Second Year Partnership with Newcastle
  • Regeneron and Sanofi Achieve Milestone with Dupixent's EU Progress
  • Exciting Developments: FDA Approves LBL-047 for Autoimmune Disease
  • Discovering Anhui: A Blend of Innovation and Heritage
  • Bolivia's Inflation Sparks Adoption of USDT by Major Auto Brands
  • Revolutionizing GRC: Discover Hyperproof AI for Growth
  • Revolutionizing Fintech: The New Age of Payments and AI
  • Recent Developments in CEA Industries and Its Road Ahead
  • Reed Hastings Supports Trump's H-1B Proposal: Key Insights
  • Concerns Over Trump's $350 Billion Investment Proposal
  • Quantum Computing Inc. Secures $500 Million Through Private Placement
  • SEMI Responds to Recent U.S. H1-B Visa Policy Changes
  • Shiba Inu Developer Reacts to $4 Million Security Breach
  • Quantum Computing Inc. Secures $500M Funding to Advance Growth
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site